Associated Banc Corp Cyto Dyn Inc. Transaction History

Associated Banc Corp

  • $3.37 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$0.18 - $0.28 $1,440 - $2,240
-8,000 Reduced 27.46%
21,136 $4,000
Q2 2023

Aug 07, 2023
SELL
$0.25 - $0.37 $1,250 - $1,850
-5,000 Reduced 14.65%
29,136 $7,000
Q1 2022

May 11, 2022
BUY
$0.37 - $1.02 $12,630 - $34,818
34,136 New
34,136 $13,000

Others Institutions Holding CYDY

# of Institutions
9
Shares Held
406K
Call Options Held
0
Put Options Held
0
View Full List

About CytoDyn Inc.

CYDY Quotes by TradingView
  • Ticker CYDY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 813,040,000
  • Market Cap $97.6M
  • Description
  • CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...
More about CYDY
Track This Portfolio

Track Associated Banc Corp Portfolio

Follow Associated Banc Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email